UK High Court Upholds Alvotech's Right to Manufacture AVT06, a Biosimilar to Eylea

Alvotech has won a UK High Court case against Regeneron and Bayer, paving the way for the manufacture and market entry of AVT06, a biosimilar to Eylea. The court rejected the injunction request, allowing Alvotech to continue manufacturing and storing AVT06 in the UK for distribution in the UK, EEA, and other countries after the expiry date for Supplementary Protection Certificates for Eylea. The decision supports commercial launches of Alvotech's biosimilar in Europe and other regions after November 23, 2025.